AA
60
-3
AVB
42
-2
ACN
43
-4
AMGN
31
-16
AON
67
-4
BIIB
46
-4
APA
44
2
AVGO
42
2
APD
52
-7
AEP
62
-5
AMP
61
-2
AME
59
6
AES
38
-5
BF.B
55
-3
AIG
51
-2
BDX
49
-10
AMAT
60
6
ALL
43
-2
ADM
54
-2
ALLE
50
-5
AA
60
-3
AVB
42
-2
ACN
43
-4
AMGN
31
-16
AON
67
-4
BIIB
46
-4
APA
44
2
AVGO
42
2
APD
52
-7
AEP
62
-5
AMP
61
-2
AME
59
6
AES
38
-5
BF.B
55
-3
AIG
51
-2
BDX
49
-10
AMAT
60
6
ALL
43
-2
ADM
54
-2
ALLE
50
-5
Financhill
Back

Franklin Street Properties Vs. Cidara Therapeutics Industry Stock Comparison

Sell
34

FSP
Franklin Street Properties

Last Price:
$1.68
Seasonality Move:
-4.23%
Buy
70

CDTX
Cidara Therapeutics

Last Price:
$62.71
Seasonality Move:
-9.13%
Sell
34
Franklin Street Properties (FSP) is a Sell

Is Franklin Street Properties a Buy, Sell or Hold?

  • The current Franklin Street Properties [FSP] share price is $1.69. The Score for FSP is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • FSP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
70
Cidara Therapeutics (CDTX) is a Buy

Is Cidara Therapeutics a Buy, Sell or Hold?

  • The current Cidara Therapeutics [CDTX] share price is $61.85. The Score for CDTX is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
  • CDTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

FSP Stock Price Chart

What is Franklin Street Properties's stock price today?

  • The Franklin Street Properties share price today is $1.69
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FSP is experiencing buying pressure, which is a positive indicator for future bullish movement.

CDTX Stock Price Chart

What is Cidara Therapeutics's stock price today?

  • The Cidara Therapeutics share price today is $61.85
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

FSP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.41 Buy
Relative Strength Index (14 RSI): 49.59 Sell
Chaikin Money Flow: 119187 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

CDTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 7.15 Buy
Relative Strength Index (14 RSI): 70.27 Buy
Chaikin Money Flow: -100733 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

FSP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.66 Buy
20-day SMA: 1.69 Buy
50-day SMA: 1.74 Sell
200-day SMA: 1.77 Sell
8-day EMA: 1.62 Buy
20-day EMA: 1.26 Buy
50-day EMA: 0.72 Buy
200-day EMA: 0.22 Buy

CDTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 59.56 Buy
20-day SMA: 53.91 Buy
50-day SMA: 37.68 Buy
200-day SMA: 24 Buy
8-day EMA: 59.74 Buy
20-day EMA: 53.31 Buy
50-day EMA: 42.08 Buy
200-day EMA: 26.97 Buy

Franklin Street Properties Earnings Growth & FSP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Cidara Therapeutics Earnings Growth & CDTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $3.78 per share, a decrease next quarter of $0.00 per share, an increase this year of $15.76 per share, and a decrease next year of $0.53 per share.

Franklin Street Properties Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cidara Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):